Gastrointestinal Cancer Area
"Each diagnosis is carefully established by all the specialists from the area, whereas the treatment plan is adjusted to the particular needs of each particular case and patient"
DR. CARLOS PASTOR IDOATE COORDINATOR. GASTROINTESTINAL CANCER AREA
The Gastrointestinal Cancer Area of the Cancer Center Clínica Universidad de Navarra is formed by a multidisciplinary team of experts with the aim of coordinating the diagnosis and treatment of those patients who come to the Clinic at its two sites with oncological diseases of the digestive tract in the esophago-gastric and colorectal spheres.
This unit is integrated by specialists in Digestive System, Radiology, Pathological Anatomy, Digestive Surgery and Medical and Radiation Oncology. In addition, it has an Area Nurse specifically dedicated to the follow-up and management of patient tests and treatments.
The Area, in its two sites simultaneously, meets weekly in the Multidisciplinary Committee in order to plan treatments and tests according to the best scientific evidence available at the time. In a coordinated manner, an individualized treatment plan is designed for each patient. The Committee also carries out the molecular and genetic studies necessary to detect and treat those patients suspected of having a hereditary oncological syndrome.
We design and carry out different lines of research in oncological diseases of the gastrointestinal tract, as well as coordinating the participation of patients in different open clinical trials on new oncological treatments.
A PERSONALIZED MEDICINE
peace of mind
Request a second opinion from our professionals with great experience in the diagnosis and treatment of oncological diseases
In 3 days, without leaving home.
Advanced diagnosis and treatment for digestive tumours
IN NAVARRE AND MADRID
Advanced treatments for better care
IN NAVARRE AND MADRID
Surgery for tumours of the digestive tract consists of removing the tumour with sufficiently wide margins as well as the main arterial and venous vessels that nourish the intestinal segment in which the tumour is located and the regional lymph nodes. The resection is performed by conventional means or by laparoscopic surgery, with a smaller incision and a faster post-operative period.
For greater success, surgical treatment is combined with chemotherapy and radiotherapy programmes to achieve better remission of the disease. We rely on the latest technology to apply radiotherapy and minimize damage to healthy tissues and possible adverse effects.
The Clínica Universidad de Navarra designs vaccines with the aim of delaying or detaining the progression of the cancer, reducing the tumour, preventing its reappearance and eliminating possible cells that have not been eliminated with alternative treatments.
Do you need to request a consultation with one of our specialists?
Created in order to determine if there is a genetic predisposition and to determine the possibility of contracting the tumoural disease in relatives of patients and, in this case, to provide them with the appropriate follow-up to avoid it.
Between 3% and 5% of colon cancer cases occur as a result of inheriting an altered gene, so a genetic study based on a family background should be carried out.
We have a team of nurses who specialize in the patient's care and attention in order to ensure the best quality of life for the patient throughout the entire process.
Our technology is the most advanced in the country for a precise diagnosis and the possibility of offering you the most successful treatment for your particular case.
Why choose the Clinic?
- Integral evaluation of the patient.
- Cutting-edge technology.
- National reference professionals.
Our team of professionals
Wealth of experience in the development of advanced therapies against digestive tumours
We develop research projects on diagnosis and treatment of colorectal cancer together with researchers from the Cima Universidad de Navarra.
Participation in these trials provides patients with new possibilities by allowing access to the latest therapeutic advances.